Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Translocator Protein 18 kDa (TSPO) Expression in Multiple Sclerosis Patients.
Perivascular spaces in MS patients at 7 Tesla MRI: A marker of neurodegeneration?
Involvement of JAK/STAT signaling in the effect of cornel iridoid glycoside on experimental autoimmune encephalomyelitis amelioration in rats.
Disability Identity Predicts Lower Anxiety and Depression in Multiple Sclerosis.
A case of Guillain-Barré syndrome with meningeal irritation.
Identification in silico and experimental validation of novel phosphodiesterase 7 inhibitors with efficacy in experimental autoimmune encephalomyelitis mice.
Teriflunomide for oral therapy in multiple sclerosis.
Multiple sclerosis: Study in MS reveals impairments in 'theory of mind'
Prevalence of Incidental Narrowing of the Superior Segment of the Internal Jugular Vein in Patients Without Multiple Sclerosis.
Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand.
The safety risks of innovation: the FDA's Expedited Drug Development Pathway.
Myelin-derived lipids modulate macrophage activity by liver x receptor activation.
The visual pathway as a model to understand brain damage in multiple sclerosis.
Common mechanisms in neurodegeneration and neuroinflammation: a BrainNet Europe gene expression microarray study.
Multiple Sclerosis State of the Art (SMART): A Qualitative and Quantitative Analysis of Therapy's Adherence, Hospital Reliability's Perception, and Services Provided Quality.
The Gut Microbiome and the Brain.
[Effects of shugan jianpi gusui recipe on multiple sclerosis recurrence: a primary report].
Accelerometry as a measure of walking behavior in multiple sclerosis.
Optic Nerve and its Arterial-Venous Vascularization: An Ultrasonologic Study in Multiple Sclerosis Patients and Healthy Controls.
Imaging Cortical Damage and Dysfunction in Multiple Sclerosis.
Frequent early multiple sclerosis relapses during treatment with fingolimod: a paradoxical effect?
A simple test of choice stepping reaction time for assessing fall risk in people with multiple sclerosis.
Fingolimod in the treatment of relapsing-remitting multiple sclerosis: long-term experience and an update on the clinical evidence.
Epileptic seizures in Japanese patients with multiple sclerosis and neuromyelitis optica.
Effects of exercise training on fatigue in multiple sclerosis: a meta-analysis.
Pages
« first
‹ previous
…
277
278
279
280
281
282
283
284
285
…
next ›
last »